Search

Your search keyword '"Zhang, Lingjian"' showing total 127 results
Start Over Author "Zhang, Lingjian"
127 results on '"Zhang, Lingjian"'

9. Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy.

Author

Zhang, Yaqi, Zhan, Luqi, Zhang, Lingjian, Shi, Qingmiao, and Li, Lanjuan

Abstract

Branched-chain amino acids (BCAAs), as essential amino acids, engage in various physiological processes, such as protein synthesis, energy supply, and cellular signaling. The liver is a crucial site for BCAA metabolism, linking the changes in BCAA homeostasis with the pathogenesis of a variety of liver diseases and their complications. Peripheral circulating BCAA levels show complex trends in different liver diseases. This review delineates the alterations of BCAAs in conditions including non-alcoholic fatty liver disease, hepatocellular carcinoma, cirrhosis, hepatic encephalopathy, hepatitis C virus infection, and acute liver failure, as well as the potential mechanisms underlying these changes. A significant amount of clinical research has utilized BCAA supplements in the treatment of patients with cirrhosis and liver cancer. However, the efficacy of BCAA supplementation in clinical practice remains uncertain and controversial due to the heterogeneity of studies. This review delves into the complicated relationship between BCAAs and liver diseases and tries to untangle what role BCAAs play in the occurrence, development, and outcomes of liver diseases. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. Additional file 2 of SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma

Author

Hu, Qingqing, Liu, Qiuhong, Zhao, Yalei, Zhang, Lingjian, and Li, Lanjuan

Abstract

Additional file 2: Fig. S1. High expression of SGOL2 in HCC in public database. Fig. S2. The mRNA and protein levels of SGOL1 after the knockdown of SGOL2 in HCC cell lines. Fig. S3. Subgroup expression analysis of SGOL2 in HCC. Fig. S4. Elevated expression of SGOL2 indicated a poor prognosis in HCC patients. Fig. S5. SGOL2 mutations and the associations between SGOL2 and immune cells in HCC. Fig. S6. Genes related to SGOL2 or MAD2 in HCC. Fig. S7. Hub gene analysis. Fig. S8. The predicted transcription factors binding to SGOL2 or MAD2.

Published
2022
Full Text
View/download PDF

40. Aneurysm and Artery Dissection Following the use of Vascular Endothelial Growth Factor Inhibitor: A Real-World Analysis Using a Spontaneous Reporting System

Author

Jian Gong, WANG Shuyue, CHEN Mingzhu, ZHANG Xinghui, ZHANG Lingjian, JIA Min, SHEN Zhiwen, WANG Junyan, XU Jing, ZHENG Zheng, WANG Mengmeng, LV Xuanrui, ZONG Xiaoyu, LI Hui, ZHOU Jin, MENG Tong, Bin Zhao, and GONG Jian

Abstract

Background: There are few real-world studies comparing the incidence, clinical features, and prognosis of aneurysm and artery dissection related to various vascular endothelial growth factor inhibitor (VPI) regimens. This study evaluated the recent evidence of aneurysm and artery dissection after VPI therapy. The purpose was to evaluate and compare the links between different VPIs and aneurysm and artery dissection by investigating the Food and Drug Administration Adverse Event Reporting System (FAERS).Methods: Using FAERS data from January 2004 to March 2020, disproportionality analysis was used for data mining to screen suspected aneurysm and artery dissection cases after different VPI treatments. The times to onset and fatality rates of suspected drugs were also investigated to assess prognoses.Results: In total, there were 634 reports of aneurysm and artery dissection events after VPI. Ramucirumab appeared to have a stronger association than other VPIs, based on the reporting odds ratio (ROR = 3.68, 95% [2.18, 6.23]). The results showed a significant difference in onset time (P < 0.001), and a quick onset occurred in 60.13% of cases. The median time to aneurysm and artery dissection was 79.5 (IQR: 19–273.5) days after VPI administration. The results also showed that men were more affected than women (59.68% vs. 40.32%), and patients older than 45 years were more affected than younger patients (68.12% vs. 3.93%). Finally, the suspected drugs generally led to a 19.98% fatality rate and a 29.81% hospitalization rate. The highest death rate was associated with Aflibercept (25.49%).Conclusions: We identified signals for aneurysm and artery dissection following various VPIs in real-world practice using the FAERS, which represents the first step for continued pharmacovigilance investigation.

Published
2020

50. Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B

Author

Wu, Daxian, primary, Rao, Qunfang, additional, Chen, Wenqian, additional, Ji, Feiyang, additional, Xie, Zhongyang, additional, Huang, Kaizhou, additional, Chen, Er'mei, additional, Zhao, Yalei, additional, Ouyang, Xiaoxi, additional, Zhang, Sainan, additional, Jiang, Zhengyi, additional, Zhang, Lingjian, additional, Xu, Linjie, additional, Gao, Hainv, additional, and Li, Lanjuan, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results